Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Faeth Therapeutics, Inc. - Common Stock (NQ:FTH)

40.43 +0.38 (+0.95%)
Streaming Delayed Price Updated: 1:32 PM EDT, Sep 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 192,399
Open 40.91
Bid (Size) 40.42 (100)
Ask (Size) 40.80 (100)
Prev. Close 40.05
Today's Range 40.03 - 42.14
52wk Range 13.43 - 41.16
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
From Faeth Therapeutics, Inc.
Via Business Wire
News headline image
Faeth Therapeutics to Participate in Upcoming September Investor Conferences
From Faeth Therapeutics
Via Business Wire

Performance

YTD
+178.3%
+178.3%
1 Month
+41.5%
+41.5%
3 Month
+178.3%
+178.3%
6 Month
+178.3%
+178.3%
1 Year
+178.3%
+178.3%

More News

Read More
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
News headline image
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer
From Faeth Therapeutics
Via Business Wire
News headline image
Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments
From Faeth Therapeutics, Inc.
Via Business Wire
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
News headline image
Faeth Therapeutics to Present PK/PD Modeling That Informed PIKTOR Dose Selection in Ongoing FTH-PIK-201 Trial at Upcoming Scientific Conference
From Faeth Therapeutics
Via Business Wire
News headline image
Faeth Therapeutics Reports Second Quarter 2026 Financial Results and Operational Updates
From Faeth Therapeutics
Via Business Wire
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire
News headline image
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Faeth Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Faeth Therapeutics, Inc. - Common Stock publicly traded?
Yes, Faeth Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Faeth Therapeutics, Inc. - Common Stock trade on?
Faeth Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Faeth Therapeutics, Inc. - Common Stock?
The ticker symbol for Faeth Therapeutics, Inc. - Common Stock is FTH on the Nasdaq Stock Market
What is the current price of Faeth Therapeutics, Inc. - Common Stock?
The current price of Faeth Therapeutics, Inc. - Common Stock is 40.43
When was Faeth Therapeutics, Inc. - Common Stock last traded?
The last trade of Faeth Therapeutics, Inc. - Common Stock was at 09/08/26 01:32 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.